Calamos Advisors’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding FSNB.WS
RCM
SCM
SIA
ETH
GAM
SBLIC
DCM
SMA
RCM
Calamos Advisors's FSNB.WS Position: Q4 2022 in Review
Calamos Advisors sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q4 2022, closing a stake of 141,666 shares — an estimated $10K sold.
Calamos Advisors first reported a position in FSNB.WS in Q3 2022 and held it in 1 quarter. The position peaked at $10K in Q3 2022. 15 funds tracked by Wall St. Rank hold FSNB.WS as of Q4 2022.
- Calamos Advisors reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Calamos Advisors sold 141,666 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $10K.
- Calamos Advisors first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q3 2022 and held it in 1 quarter.
- Calamos Advisors's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $10K in Q3 2022.
- 15 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q4 2022.
Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.